About
Profile
We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
ABT
Shares of the biotech company rose 5% after a jury in Missouri cleared Abbott of liability in a baby formula case. There are still other similar cases pending against Abbott.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Abbott Q2 results top consensus as base business offsets COVID impact
- Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
- Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
- Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
- Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
- Goldman Sachs sees rays of hope in underperforming health sector
- BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
- FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
- Medicare revises guidance on drug price negotiations amid lawsuits
- Abbott gains expanded coverage for glucose monitoring device in France
- Abbott names Philip Boudreau CFO effective Sept. 1
- Abbott Laboratories declares $0.51 dividend
- Abbott alleges former scientist in its nutrition unit stole trade secrets
- Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
- Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
- Abbott boasts of heart failure reduction data for CardioMEMS device
- Abbott, other baby-formula makers see FTC probe over collusion - report
- Abbott recalled baby formula claims tossed by federal judge
- Abbott gains approval of TactiFlex ablation catheter treatment
- Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
PEERS
Date | Price | Open | High | Low | Vol | Change | |||
---|---|---|---|---|---|---|---|---|---|
Nov 20 | 115.93 | 116.69 |
116.74
|
115.54
|
3.6M | -1.02% | |||
Nov 19 | 117.13 | 116.91 |
117.55
|
115.45
|
4.5M | -0.2% | |||
Nov 18 | 117.36 | 115.57 |
117.94
|
115.51
|
6.1M | 1.26% | |||
Nov 15 | 115.9 | 114.87 |
116.35
|
114.43
|
6.9M | 0.76% | |||
Nov 14 | 115.03 | 115.98 |
116.09
|
114.93
|
3.8M | -0.61% | |||
Nov 13 | 115.74 | 116.08 |
116.81
|
115.55
|
4.8M | -0.6% | |||
Nov 12 | 116.44 | 116.68 |
117.3
|
116.42
|
4.6M | -0.31% | |||
Nov 11 | 116.8 | 116.94 |
117.84
|
116.33
|
5.3M | 0.18% | |||
Nov 8 | 116.59 | 115.33 |
117.25
|
114.69
|
5.7M | 1.12% | |||
Nov 7 | 115.3 | 117.49 |
117.49
|
114.54
|
5.5M | -1.28% | |||
Nov 6 | 116.8 | 121 |
121
|
115.5
|
5.3M | -0.79% | |||
Nov 5 | 117.73 | 117.59 |
118.25
|
116.33
|
4.1M | 0.07% | |||
Nov 4 | 117.65 | 119.6 |
120.57
|
117.48
|
5.6M | -0.8% | |||
Nov 1 | 118.6 | 119.75 |
119.92
|
117.09
|
10.1M | 4.61% | |||
Oct 31 | 113.37 | 113.57 |
114.47
|
113.27
|
5.3M | -0.94% | |||
Oct 30 | 114.45 | 112.64 |
114.74
|
112.5
|
5.2M | 0.93% | |||
Oct 29 | 113.4 | 114.14 |
114.74
|
113.35
|
4.5M | -0.59% | |||
Oct 28 | 114.07 | 114.77 |
114.83
|
113.55
|
4.1M | -0.13% | |||
Oct 25 | 114.22 | 116.14 |
116.39
|
113.2
|
6.0M | -1.99% | |||
Oct 24 | 116.54 | 117.21 |
117.41
|
116.21
|
3.8M | -0.4% | |||
Oct 23 | 117.01 | 116.16 |
117.15
|
115.93
|
3.7M | 0.77% | |||
Oct 22 | 116.12 | 116.86 |
117.2
|
115.84
|
5.4M | -0.74% | |||
Oct 21 | 116.99 | 118.89 |
118.92
|
116.6
|
8.3M | -2.01% | |||
Oct 18 | 119.39 | 117.9 |
119.85
|
117.67
|
6.7M | 1.27% | |||
Oct 17 | 117.89 | 118.71 |
118.76
|
117.19
|
5.0M | 0.06% | |||
Oct 16 | 117.82 | 118.01 |
119.52
|
116.64
|
7.4M | 1.53% | |||
Oct 15 | 116.05 | 116.75 |
118.36
|
115.81
|
6.5M | -1.02% | |||
Oct 14 | 117.25 | 116.26 |
117.58
|
115.98
|
3.7M | 0.97% | |||
Oct 11 | 116.12 | 116.21 |
117.28
|
115.94
|
3.5M | 0.43% | |||
Oct 10 | 115.62 | 116.21 |
116.85
|
115.45
|
4.1M | -0.28% | |||
Oct 9 | 115.95 | 114.98 |
116.27
|
114.56
|
4.3M | 1.15% | |||
Oct 8 | 114.63 | 113.75 |
115.29
|
113.75
|
4.3M | 1.12% | |||
Oct 7 | 113.36 | 112.3 |
113.61
|
111.8
|
6.9M | 0.64% | |||
Oct 4 | 112.64 | 112.13 |
112.75
|
111.68
|
4.4M | 0.37% | |||
Oct 3 | 112.23 | 113.5 |
113.51
|
111.79
|
3.5M | -1.24% | |||
Oct 2 | 113.64 | 113.38 |
113.79
|
112.03
|
3.5M | 0.07% | |||
Oct 1 | 113.56 | 114.21 |
114.22
|
112.8
|
4.3M | -0.39% | |||
Sep 30 | 114.01 | 112.57 |
114.09
|
112.1
|
5.0M | 1.41% | |||
Sep 27 | 112.43 | 112.93 |
113.38
|
112.32
|
3.6M | -0.27% | |||
Sep 26 | 112.73 | 112.31 |
112.93
|
112.1
|
3.5M | 0.11% | |||
Sep 25 | 112.61 | 113.82 |
114.19
|
111.85
|
5.2M | -0.64% | |||
Sep 24 | 113.34 | 114.21 |
114.41
|
113.18
|
5.0M | -1.28% | |||
Sep 23 | 114.81 | 113.79 |
114.9
|
112.96
|
5.0M | 0.98% | |||
Sep 20 | 113.7 | 113.75 |
114.16
|
113.2
|
8.4M | -0.39% | |||
Sep 19 | 114.15 | 115.49 |
115.66
|
113.25
|
8.1M | -0.64% | |||
Sep 18 | 114.88 | 117.5 |
117.5
|
114.52
|
6.0M | -2.75% | |||
Sep 17 | 118.13 | 117.8 |
118.54
|
117.26
|
5.0M | 0.43% | |||
Sep 16 | 117.63 | 117 |
117.68
|
116.42
|
3.6M | 1.06% | |||
Sep 13 | 116.4 | 116.02 |
117.05
|
115.94
|
3.4M | -0.37% | |||
Sep 12 | 116.83 | 116.5 |
117.31
|
115.59
|
4.3M | 0.20% | |||
Sep 11 | 116.6 | 116.39 |
116.72
|
114.72
|
6.5M | -0.44% | |||
Sep 10 | 117.11 | 116.15 |
117.25
|
115.43
|
5.0M | 0.58% | |||
Sep 9 | 116.43 | 114.46 |
116.73
|
114.32
|
5.1M | 2.26% | |||
Sep 6 | 113.86 | 113.63 |
114.34
|
113.01
|
3.8M | 0.67% | |||
Sep 5 | 113.1 | 114.26 |
114.48
|
112.52
|
2.9M | -1.14% | |||
Sep 4 | 114.4 | 114.69 |
115.59
|
113.57
|
3.7M | -0.23% | |||
Sep 3 | 114.66 | 113.36 |
114.83
|
113.36
|
4.4M | 1.23% | |||
Aug 30 | 113.27 | 113 |
113.47
|
111.89
|
4.3M | 0.45% | |||
Aug 29 | 112.76 | 113.29 |
113.5
|
112.52
|
3.4M | -0.12% | |||
Aug 28 | 112.9 | 113.1 |
113.42
|
112.37
|
3.8M | 0% |